HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Degrève Selected Research

ganciclovir elaidate

12/2000Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Degrève Research Topics

Disease

3Neoplasms (Cancer)
04/2001 - 02/2000
2Osteosarcoma (Osteogenic Sarcoma)
02/2001 - 12/2000
1Herpesviridae Infections (Herpesvirus Infection)
04/2001
1Carcinoma (Carcinomatosis)
09/2000
1Chickenpox
02/2000
1Herpes Zoster
02/2000
1Gliosarcoma
02/2000
1Breast Neoplasms (Breast Cancer)
02/2000

Drug/Important Bio-Agent (IBA)

3Thymidine KinaseIBA
02/2001 - 02/2000
3brivudine (brivudin)IBA
02/2001 - 02/2000
2NucleosidesIBA
02/2001 - 12/2000
2pyrimidineIBA
02/2001 - 12/2000
2Cytostatic AgentsIBA
02/2001 - 12/2000
1cyclohexenyl-GIBA
04/2001
1Antineoplastic Agents (Antineoplastics)IBA
04/2001
1Antiviral Agents (Antivirals)IBA
04/2001
1Arabinofuranosyluracil (Ara U)IBA
02/2001
1Thymidylate SynthaseIBA
02/2001
1dTMP kinaseIBA
02/2001
1DeoxyuridineIBA
12/2000
1purineIBA
12/2000
1Purine NucleosidesIBA
12/2000
1ganciclovir elaidateIBA
12/2000
1Ganciclovir (Cytovene)FDA LinkGeneric
09/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
04/2001
1Therapeutics
02/2001